Using Exenatide Twice Daily or Insulin in Clinical Practice: Results from CHOICE

被引：0
|
作者：
Chantal Mathieu
Claes-Göran Östenson
Stephan Matthaei
Matthew Reaney
Thure Krarup
Bruno Guerci
Jacek Kiljański
Carole Salaun-Martin
Hélène Sapin
Michael Theodorakis
机构：
[1] UZ Gasthuisberg,Department of Endocrinology
[2] Karolinska Institutet,Department of Molecular Medicine and Surgery
[3] Diabetes-Center Quakenbrück,Department of Endocrinology I
[4] Eli Lilly,Diabetologie, Maladies Metaboliques & Nutrition, Hôpital Brabois
[5] Bispebjerg Hospital,Department of Clinical Therapeutics
[6] CHU de Nancy,undefined
[7] et CIC Inserm,undefined
[8] ILCV,undefined
[9] Eli Lilly,undefined
[10] Eli Lilly,undefined
[11] University of Athens School of Medicine,undefined
来源：
Diabetes Therapy | 2013年 / 4卷
关键词：
Diabetes mellitus; Exenatide; Insulin; Injectable therapy; Type 2;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：285 / 308
页数：23
相关论文
共 50 条
  • [1] Using Exenatide Twice Daily or Insulin in Clinical Practice: Results from CHOICE
    Mathieu, Chantal
    Ostenson, Claes-Goran
    Matthaei, Stephan
    Reaney, Matthew
    Krarup, Thure
    Guerci, Bruno
    Kiljanski, Jacek
    Salaun-Martin, Carole
    Sapin, Helene
    Theodorakis, Michael
    [J]. DIABETES THERAPY, 2013, 4 (02) : 285 - 308
  • [2] Patients with type 2 diabetes initiating exenatide twice daily or insulin in clinical practice: CHOICE study
    Matthaei S.
    Reaney M.
    Mathieu C.
    Östenson C.-G.
    Krarup T.
    Guerci B.
    Kiljanski J.
    Petto H.
    Bruhn D.
    Theodorakis M.
    [J]. Diabetes Therapy, 2012, 3 (1) : 1 - 15
  • [3] Treatment outcomes after initiation of exenatide twice daily or insulin in clinical practice: 12-month results from CHOICE in six European countries
    Ostenson, Claes-Goran
    Matthaei, Stephan
    Reaney, Matthew
    Krarup, Thure
    Guerci, Bruno
    Kiljanski, Jacek
    Salaun-Martin, Carole
    Sapin, Helene
    Bruhn, David
    Mathieu, Chantal
    Theodorakis, Michael
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2013, 6 : 171 - 184
  • [4] Patient-reported outcomes among patients using exenatide twice daily or insulin in clinical practice in six European countries: the CHOICE prospective observational study
    Matthew Reaney
    Chantal Mathieu
    Claes-Göran Östenson
    Stephan Matthaei
    Thure Krarup
    Jacek Kiljański
    Carole Salaun-Martin
    Hélène Sapin
    Michael Theodorakis
    Bruno Guerci
    [J]. Health and Quality of Life Outcomes, 11
  • [5] Patient-reported outcomes among patients using exenatide twice daily or insulin in clinical practice in six European countries: the CHOICE prospective observational study
    Reaney, Matthew
    Mathieu, Chantal
    Ostenson, Claes-Goran
    Matthaei, Stephan
    Krarup, Thure
    Kiljanski, Jacek
    Salaun-Martin, Carole
    Sapin, Helene
    Theodorakis, Michael
    Guerci, Bruno
    [J]. HEALTH AND QUALITY OF LIFE OUTCOMES, 2013, 11
  • [6] Clinical Outcomes of Elderly Patients Initiating Exenatide Twice Daily Compared to Insulin Glargine
    Pawaskar, Manjiri
    Li, Qian
    [J]. DIABETES, 2012, 61 : A608 - A609
  • [7] Resource use and costs of exenatide bid or insulin in clinical practice: the European CHOICE study
    Kiiskinen, Urpo
    Matthaei, Stephan
    Reaney, Matthew
    Mathieu, Chantal
    Oestenson, Claes-Goean
    Krarup, Thure
    Theodorakis, Michael
    Kiljanski, Jacek
    Salaun-Martin, Carole
    Sapin, Helene
    Guerci, Bruno
    [J]. CLINICOECONOMICS AND OUTCOMES RESEARCH, 2013, 5 : 355 - 367
  • [8] Differences between patients initiating insulin and exenatide in clinical practice in Greece (the CHOICE study)
    Theodorakis, M. J.
    Aloumanis, K.
    Drossinos, E.
    [J]. ARCHIVES OF HELLENIC MEDICINE, 2012, 29 (03): : 336 - 344
  • [9] Addition of exenatide twice daily to basal insulin for the treatment of type 2 diabetes: clinical studies and practical approaches to therapy
    Tobin, G. S.
    Cavaghan, M. K.
    Hoogwerf, B. J.
    McGill, J. B.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2012, 66 (12) : 1147 - 1157
  • [10] Long-term changes in cardiovascular risk markers during administration of exenatide twice daily or glimepiride: results from the European exenatide study
    Rafael Simó
    Bruno Guerci
    Guntram Schernthaner
    Baptist Gallwitz
    Juan Rosas-Guzmàn
    Francesco Dotta
    Andreas Festa
    Ming Zhou
    Jacek Kiljański
    [J]. Cardiovascular Diabetology, 14
12345